Julia G. Butchko, Chief Development Officer at Immunovant, Inc. (IMVT), sold 5,565 shares at $29.64 ($165K) on 2024-07-17, disclosed to the SEC on 2024-07-19.
Open-market sale of $165k IMVT by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.64 | 2,698 | $80K | 48.4% |
| 2 | $29.64 | 2,698 | $80K | 48.4% |
| 3 | $30.55 | 169 | $5K | 3.1% |
| Total | $29.67 avg | 5,565 | $165K | 100% |
| Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |
| IMVT | SELL | 2024-04-10 | $33K | — | Filing → |